Literature DB >> 1846186

Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm.

A P Cullen1, R Reid, M Campion, A T Lörincz.   

Abstract

The integration of human papillomavirus (HPV) DNA into the human genome has been generally accepted as a characteristic of malignant lesions. To gain a better understanding of this phenomenon, genomic DNA from 181 cervical biopsy specimens was isolated and analyzed for HPV type and physical state of the HPV genome. These specimens represented the full spectrum of cervical disease, from condyloma to invasive carcinoma. Discrimination between integrated and episomal HPV DNA was accomplished by the detection of HPV-human DNA junction fragments on Southern blots. In most cases in which ambiguous Southern blot results were obtained, the specimens were reanalyzed by two-dimensional gel electrophoresis. Of the 100 biopsy specimens of cervical intraepithelial neoplasia analyzed, only 3 showed integrated HPV DNA, in contrast to 56 (81%) of 69 cervical carcinomas (P less than 0.001) showing integrated HPV DNA. Of the 40 carcinomas containing HPV 16 DNA, 29 (72%) had integrated HPV DNA, of which 8 (20%) also had episomal HPV DNA. In 11 (27%) cancers, only episomal HPV 16 DNA was detected. All 23 HPV 18-containing carcinomas had integrated HPV DNA, and 1 also had episomal HPV 18 DNA. The difference between HPV types 16 and 18 with respect to frequency of integration was statistically significant (P less than 0.01). The results of this study indicate that detectable integration of HPV DNA, regardless of type, occurs infrequently in cervical intraepithelial neoplasia. The absence of HPV 16 DNA integration in some carcinomas implies that integration is not always required for malignant progression. In contrast, the consistent integration of HPV 18 DNA in all cervical cancers examined may be related to its greater transforming efficiency in vitro and its reported clinical association with more aggressive cervical cancers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846186      PMCID: PMC239798     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix.

Authors:  J Walker; J D Bloss; S Y Liao; M Berman; S Bergen; S P Wilczynski
Journal:  Obstet Gynecol       Date:  1989-11       Impact factor: 7.661

2.  Cloning and partial DNA sequencing of two new human papillomavirus types associated with condylomas and low-grade cervical neoplasia.

Authors:  A T Lörincz; A P Quinn; M D Goldsborough; B J Schmidt; G F Temple
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes.

Authors:  M S Barbosa; R Schlegel
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

4.  Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases?

Authors:  P G Fuchs; F Girardi; H Pfister
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

5.  Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line.

Authors:  K B Choo; W F Cheung; L N Liew; H H Lee; S H Han
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers.

Authors:  T Matsukura; S Koi; M Sugase
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

7.  Episomal HPV 16 DNA isolated from a cervical carcinoma presents a partial duplication of the early region.

Authors:  D Di Luca; E Caselli; P Monini; A Rotola; A Savioli; E Cassai
Journal:  Virus Res       Date:  1989-09       Impact factor: 3.303

8.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

Authors:  C Yee; I Krishnan-Hewlett; C C Baker; R Schlegel; P M Howley
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

9.  Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma.

Authors:  K B Choo; H H Lee; C C Pan; S M Wu; L N Liew; W F Cheung; S H Han
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.

Authors:  M Dürst; L Gissmann; H Ikenberg; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  122 in total

1.  Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer.

Authors:  E Guerrero; R W Daniel; F X Bosch; X Castellsagué; N Muñoz; M Gili; P Viladiu; C Navarro; M L Zubiri; N Ascunce
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 2.  Laboratory techniques in the investigation of human papillomavirus infection.

Authors:  E M de Villiers
Journal:  Genitourin Med       Date:  1992-02

3.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Human papilloma virus DNA: a factor in the pathogenesis of mammary Paget's disease?

Authors:  K Czerwenka; F Heuss; J W Hosmann; M Manavi; Y Lu; D Jelincic; E Kubista
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Cosette M Wheeler; Denise A Galloway; Constance Mao; Jesse Ho; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

6.  Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification.

Authors:  M A Ozbun; C Meyers
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

7.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Diagnosis of genital infection caused by human papillomavirus using in situ hybridisation: the importance of the size of the biopsy specimen.

Authors:  F Gómez; M T Corcuera; E Muñoz; M Roldan; M J Alonso; M Abad; J I Paz; A López-Bravo
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

9.  Tetraarsenic oxide-mediated apoptosis in a cervical cancer cell line, SiHa.

Authors:  Jeong Kim; Su-Mi Bae; Dae-Seog Lim; Sun-Young Kwak; Chang-Ki Lee; Yong-Seok Lee; Il-Ju Bae; Jin-Young Yoo; Young-Joo Lee; Chong-Kook Kim; Woong-Shick Ahn
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

10.  Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR.

Authors:  Krzysztof Lukaszuk; Joanna Liss; Izabela Wozniak; Janusz Emerich; Czesław Wójcikowski
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.